Published in J Med Microbiol on October 01, 2003
Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev (2006) 6.03
Detection of respiratory viruses by molecular methods. Clin Microbiol Rev (2008) 3.03
A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. J Virol (2009) 1.63
Human rhinovirus C associated with wheezing in hospitalised children in the Middle East. J Clin Virol (2009) 1.44
Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats. J Virol (2007) 1.24
Simultaneous detection of influenza A, influenza B, and respiratory syncytial viruses and subtyping of influenza A H3N2 virus and H1N1 (2009) virus by multiplex real-time PCR. J Clin Microbiol (2011) 1.14
Human metapneumovirus in hospitalized children in Amman, Jordan. J Med Virol (2010) 0.98
Identification of upper respiratory tract pathogens using electrochemical detection on an oligonucleotide microarray. PLoS One (2007) 0.94
A sensitive real-time PCR for detection and subgrouping of human respiratory syncytial virus. J Virol Methods (2011) 0.92
Burden of respiratory syncytial virus in hospitalized infants and young children in Amman, Jordan. Scand J Infect Dis (2010) 0.90
A nonviral pHEMA+chitosan nanosphere-mediated high-efficiency gene delivery system. Int J Nanomedicine (2013) 0.86
A two-step lyssavirus real-time polymerase chain reaction using degenerate primers with superior sensitivity to the fluorescent antigen test. Biomed Res Int (2014) 0.85
Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus. Adv Virol (2013) 0.84
Molecular and clinical characteristics of respiratory syncytial virus infections in hospitalized children. Med Microbiol Immunol (2005) 0.83
Epidemiological analysis of respiratory viral etiology for influenza-like illness during 2010 in Zhuhai, China. Virol J (2013) 0.82
Screening for respiratory syncytial virus and isolation strategies in children hospitalized with acute respiratory tract infection. Medicine (Baltimore) (2014) 0.81
High-throughput screening normalized to biological response: application to antiviral drug discovery. J Biomol Screen (2013) 0.80
Sensitive commercial NASBA assay for the detection of respiratory syncytial virus in clinical specimen. PLoS One (2007) 0.80
Two-Step versus One-Step RNA-to-CT 2-Step and One-Step RNA-to-CT 1-Step: validity, sensitivity, and efficiency. J Biomol Tech (2009) 0.80
Role of human metapneumovirus, influenza A virus and respiratory syncytial virus in causing WHO-defined severe pneumonia in children in a developing country. PLoS One (2013) 0.78
Gold nanorods inhibit respiratory syncytial virus by stimulating the innate immune response. Nanomedicine (2016) 0.75
Immunogenicity of RSV F DNA Vaccine in BALB/c Mice. Adv Virol (2016) 0.75
Costs of hospitalization with respiratory syncytial virus illness among children aged <5 years and the financial impact on households in Bangladesh, 2010. J Glob Health (2017) 0.75
Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription. EMBO J (2001) 2.08
The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virus. J Immunol Methods (1988) 2.04
Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons. EMBO J (1999) 1.50
Resistance of HIV type 1 to proteinase inhibitor Ro 31-8959. AIDS Res Hum Retroviruses (1995) 1.45
[Global warming: trailblazer for tropical infections in Germany?]. Dtsch Med Wochenschr (2007) 1.44
HIV-1 infection by artificial insemination. Lancet (1998) 1.44
The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis. Proc Natl Acad Sci U S A (1992) 1.24
Regional variations in cortical modeling in the femoral mid-shaft: sex and age differences. Am J Phys Anthropol (2000) 1.11
Shortening of the diagnostic window with a new combined HIV p24 antigen and anti-HIV-1/2/O screening test. J Virol Methods (2000) 1.10
On the mechanism of skin wound "contraction": a granulation tissue "knockout" with a normal phenotype. Proc Natl Acad Sci U S A (1995) 1.05
Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris. J Immunol (1995) 1.02
Comparison of human herpesvirus 8 and Epstein-Barr virus seropositivity among children in areas endemic and non-endemic for Kaposi's sarcoma. J Med Virol (2004) 1.02
First case of HIV-1 subtype 0 infection in Germany. Infection (1996) 1.00
Screening of Nepalese medicinal plants for antiviral activity. J Ethnopharmacol (2001) 0.99
Evaluation of immunoassays for detection of antibodies to human herpesvirus 7. Clin Diagn Lab Immunol (1996) 0.99
Tissue donation and virus safety: more nucleic acid amplification testing is needed. Transpl Infect Dis (2010) 0.97
Class II (DR) antigen expression on CD8+ lymphocyte subsets in acquired immune deficiency syndrome (AIDS). J Clin Immunol (1988) 0.95
Detection of genetically diverse human immunodeficiency virus type 1 group M and O isolates by PCR. J Clin Microbiol (1997) 0.95
Single-shot pulse duration monitor for extreme ultraviolet and X-ray free-electron lasers. Nat Commun (2013) 0.94
Anchoring complex components laminin-5 and type VII collagen in intestine: association with migrating and differentiating enterocytes. J Histochem Cytochem (1996) 0.93
A neutralization assay for HIV-2 based on measurement of provirus integration by duplex real-time PCR. J Virol Methods (2009) 0.93
Sensitivity and specificity of eight commercial and one recombinant anti-HIV ELISA tests. Lancet (1987) 0.92
Comparison of the efficacy of virus inactivation methods in allogeneic avital bone tissue transplants. Cell Tissue Bank (2001) 0.92
[The amino acid sequence of cytochrome c of the carp, Cyprinus carpio]. Eur J Biochem (1970) 0.92
Enterovirus RNA sequences in sera of schoolchildren in the general population and their association with type 1-diabetes-associated autoantibodies. J Med Microbiol (2005) 0.91
Human-mouse interspecies collagen I heterotrimer is functional during embryonic development of Mov13 mutant mouse embryos. Mol Cell Biol (1990) 0.90
Antiviral lanostanoid triterpenes from the fungus Ganoderma pfeifferi. Fitoterapia (2003) 0.89
Update on HIV-1 group O infection in Equatorial Guinea, Central Africa. AIDS (1997) 0.88
Coreceptor requirements of primary HIV type 1 group O isolates from Cameroon. AIDS Res Hum Retroviruses (1999) 0.87
Inhibitory effect of Bergenia ligulata on influenza virus A. Pharmazie (2003) 0.87
Human immunodeficiency virus type 1 and type 2 seroprevalence in cornea donors. Ger J Ophthalmol (1994) 0.87
Ultrasound for diagnosis of apophyseal injuries. Knee Surg Sports Traumatol Arthrosc (1996) 0.87
Multicenter evaluation of a new recombinant enzyme immunoassay for the combined detection of antibody to HIV-1 and HIV-2. AIDS (1990) 0.86
Genetic analysis of HIV type 1 group O p24gag sequences from Cameroon and Equatorial Guinea. AIDS Res Hum Retroviruses (1997) 0.86
Response of cellular antioxidants to ozone in wheat flag leaves at different stages of plant development. Environ Pollut (1994) 0.85
Analysis of the V3 loop sequences from 10 HIV type 1-infected AIDS patients from Paraguay. AIDS Res Hum Retroviruses (1995) 0.85
Paying for blood donations--still a risk? Vox Sang (2003) 0.84
Comparison of two antiretroviral triple combinations including the protease inhibitor indinavir in children infected with human immunodeficiency virus. Pediatr Infect Dis J (1998) 0.84
Epidemiology and clinical manifestation of HIV infection in northern Zaire. Eur J Epidemiol (1994) 0.84
HIV type 1 V3 serotyping of Tanzanian samples: probable reasons for mismatching with genetic subtyping. AIDS Res Hum Retroviruses (1998) 0.84
Are enterovirus infections a co-factor in sudden hearing loss? J Med Virol (2004) 0.84
Adenovirus-receptor interaction with human lymphocytes. J Med Virol (1997) 0.83
Sequence of gp41env immunodominant region of HIV type 1 group O from west central Africa. AIDS Res Hum Retroviruses (1997) 0.83
Molecular and clinical characteristics of respiratory syncytial virus infections in hospitalized children. Med Microbiol Immunol (2005) 0.83
Risk of virus transmission by jet injection. Lancet (1988) 0.83
Inhibition of HIV replication in cell culture by the specific aspartic protease inhibitor pepstatin A. FEBS Lett (1989) 0.83
Specificity and sensitivity of anti-HTLV-III/LAV determinations with a recombinant antigen competitive ELISA. Infection (1987) 0.83
Complement activation by HIV-1-infected cells: the role of transmembrane glycoprotein gp41. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.83
Flow cytometric analysis of the binding of eleven lectins to human T- and B-cells and to human T- and B-cell lines. Cytometry (1984) 0.82
A new second-generation anti-HIV-1 enzyme immunoassay using recombinant envelope and core proteins. AIDS (1988) 0.82
Inhibitory activity of 3'-fluoro-2' deoxythymidine and related nucleoside analogues against adenoviruses in vitro. Antiviral Res (1997) 0.82
Absence of hepatitis A after treatment with pasteurised factor VIII concentrates in children with haemophilia A and von Willebrand disease. Lancet (1993) 0.82
Naturally occurring sequence polymorphisms within HIV type 1 group O protease. AIDS Res Hum Retroviruses (2001) 0.82
Differential diagnosis of HIV type 1 group O and M infection by polymerase chain reaction and PstI restriction analysis of the pol gene fragment. AIDS Res Hum Retroviruses (1998) 0.81
Determinants of responsiveness to 5-fluorouridine in transplantable murine leukemias. Mol Pharmacol (1971) 0.81
Phase I/II trial with fozivudine tidoxil (BM 21.1290): a 7 day randomized, placebo-controlled dose-escalating trial. Antivir Ther (1997) 0.81
Deficit syndromes in schizophrenic patients 15 years after their first hospitalisation: preliminary results of a follow-up study. Eur Arch Psychiatry Clin Neurosci (1999) 0.81
Chlamydia pneumoniae carriage and infection in hospitalized children with respiratory tract diseases. Infection (2003) 0.81
HIV-1 and HIV-2 isolates differ in their ability to activate the complement system on the surface of infected cells. AIDS (1993) 0.81
Multiple brain abscesses in a 25-year-old patient with cystic fibrosis, successfully treated with an anti-Pseudomonas plus anti-mycobacterial antibiotic regimen. Pediatr Pulmonol (1997) 0.80
Long-term course of schizophrenic, affective and schizoaffective psychosis: focus on negative symptoms and their impact on global indicators of outcome. Acta Psychiatr Scand Suppl (2000) 0.80
Human immunodeficiency virus cannot productively infect freshly cultured human cartilage cells. ORL J Otorhinolaryngol Relat Spec (1993) 0.79
Prevalence of antibodies to hepatitis C virus (HCV) in haemophiliacs. Blut (1989) 0.79
[Cerebral seizures and/or encephalitis after MMR, oral polio, HiB or DPT vaccination?]. Kinderarztl Prax (1993) 0.79
Fluorescent focus reduction assay for the screening of antiadenoviral agents. J Virol Methods (1996) 0.79
Immunoblot test with recombinant HIV antigens. Lancet (1987) 0.78
A critical analysis of human immunodeficiency virus transmission using human cartilage allografts. Eur Arch Otorhinolaryngol (1993) 0.78
Hantavirus Dobrava infection with pulmonary manifestation. Med Microbiol Immunol (1999) 0.78
Infrequent detection of HIV-1 components in tears compared to blood of HIV-1-infected persons. Infection (1992) 0.78
Bronchial Chlamydia pneumoniae infection, markers of allergic inflammation and lung function in children. Pediatr Allergy Immunol (2001) 0.78
[The saccharin test in the pediatric broncho-pneumonologic outpatient clinic. A noninvasive screening method for the assessment of ciliary function of the respiratory tract in children]. Kinderarztl Prax (1990) 0.78
[Differences in detectability of human immunodeficiency virus type 1 in tears and blood lymphocytes]. Klin Monbl Augenheilkd (1992) 0.78
[Inactivation of HIV-1 in human femur heads using a heat disinfection system (Lobator SD-1)]. Unfallchirurg (1997) 0.78
Evaluation of a quantitative double ELISA strategy for confirmation and differentiation of HIV infection. J Virol Methods (1997) 0.78
[Transmissibility of HIV infections via allogeneic transplants]. Laryngol Rhinol Otol (Stuttg) (1987) 0.78
Comparison of ritonavir plus saquinavir- and nelfinavir plus saquinavir-containing regimens as salvage therapy in children with human immunodeficiency type 1 infection. Pediatr Infect Dis J (2000) 0.78
Evaluation of different V3 peptides in an enzyme immunoassay for specific HIV type 1 group O antibody detection. AIDS Res Hum Retroviruses (1998) 0.78
[Seroprevalence of human parvovirus B 19 antibodies (Sticker's disease/erythema infectiosum) in the DRG population]. Kinderarztl Prax (1990) 0.78
Functional characterization of a muscarinic receptor stimulating gastrin release from rabbit antral G-cells in primary culture. Eur J Pharmacol (1994) 0.78
Effect of free radical scavengers and metal ion chelators on hydrogen peroxide and phenylhydrazine induced red blood cell lipid peroxidation. Free Radic Res Commun (1987) 0.78
A new antioxidative vitamin B6 analogue modulates pathophysiological cell proliferation and damage. Bioorg Med Chem (1999) 0.77
Characterization of pseudo-islets formed from pancreatic islet cell suspensions of neonatal rats. Mol Cell Endocrinol (1983) 0.77
A rabbit bone marrow model system for evaluation of cytotoxicity: characterization of normal bone marrow cell cycle parameters by flow cytometry. J Histochem Cytochem (1980) 0.77
Monoclonal CD4 antibodies after accidental HIV infection. Lancet (1990) 0.77
Mutations in the C-terminal region of the HIV-1 reverse transcriptase and their correlation with drug resistance associated mutations and antiviral treatment. Eur J Med Res (2010) 0.77
Human immunodeficiency virus infection is prevalent in Malawi. Infection (1987) 0.76
Cyanobacteria a potential source of antiviral substances against influenza virus. Med Microbiol Immunol (2002) 0.76
Evaluation of the efficacy of 2',3'-dideoxycytidine against adenovirus infection in a mouse pneumonia model. Antiviral Res (2000) 0.76
Risperidone in treatment-refractory chronic alcohol hallucinosis. Pharmacopsychiatry (1997) 0.76
[Hemolytic anemia caused by echinocytosis in liver cirrhosis]. Dtsch Med Wochenschr (1988) 0.76
Pancreatic islet cell suspensions of newborn rats and the formation of pseudo-islets in culture. Acta Biol Med Ger (1982) 0.75
Risk of transmitting HIV by endoscopes. Endoscopy (1988) 0.75
Perinatal parvovirus B19 infections: what are the clinical consequences? Pediatr Hematol Oncol (1997) 0.75
Seroreversions in human immunodeficiency virus (HIV) infection. Ann Intern Med (1989) 0.75
Acute obstructive respiratory diseases (ARD) and bacterial complications of ARD (pneumonia, sinusitis) in infants and children associated with human herpesvirus-6 infection. Padiatr Grenzgeb (1993) 0.75
Postvaccinal thrombocytopenia: fact or myth? Pediatr Hematol Oncol (1996) 0.75